Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.97
+0.32 (3.00%)
Apr 1, 2026, 4:00 PM EDT - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $375.78 million as of April 2, 2026. Its market cap has increased by 3.24% in one year.
Market Cap
375.78M
Enterprise Value
187.97M
1-Year Change
3.24%
Ranking
Category
Stock Price
$10.97
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $375.78M, a decrease of -83.12%. That is a compound annual growth rate of -14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 375.78M | -17.62% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 375.50M |
| Armata Pharmaceuticals | 375.12M |
| XOMA Royalty | 374.03M |
| Invivyd | 367.37M |
| Autolus Therapeutics | 367.28M |
| Monopar Therapeutics | 366.74M |
| Enanta Pharmaceuticals | 366.51M |
| DiaMedica Therapeutics | 364.78M |